PP
IGMS

PDT Partners’s IGM Biosciences IGMS Stock Holding History

PDT Partners’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-10,641
Closed -$181K – 642
2022
Q4 		$181K Sell
10,641
-2,485
-19% -$49.7K 0.03% 548
2022
Q3 		$298K Sell
13,126
-1,352
-9% -$27.3K 0.05% 595
2022
Q2 		$261K Sell
14,478
-4,431
-23% -$79K 0.02% 770
2022
Q1 		$505K Buy
+18,909
New +$352K 0.04% 576
2020
Q4 		– Sell
-3,048
Closed -$225K – 764
2020
Q3 		$225K Buy
+3,048
New +$180K 0.01% 606

Other funds holding IGMS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PDT Partners's IGMS Position: Q1 2023 in Review

PDT Partners sold out of IGM Biosciences (IGMS) in Q1 2023, closing a stake of 10,641 shares — an estimated $181K sold.

PDT Partners first reported a position in IGMS in Q3 2020 and held it in 5 quarters. The position peaked at $505K in Q1 2022. 74 funds tracked by Wall St. Rank hold IGMS as of Q1 2023.

  • PDT Partners reported no remaining IGM Biosciences position as of Q1 2023 after selling out during the quarter.
  • PDT Partners sold 10,641 IGM Biosciences shares in Q1 2023, an estimated $181K.
  • PDT Partners first reported a position in IGM Biosciences in Q3 2020 and held it in 5 quarters.
  • PDT Partners's IGM Biosciences position peaked at $505K in Q1 2022.
  • 74 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2023.

Based on PDT Partners's 13F filing for Q1 2023, filed 15 May 2023.